Recent Finacing
Recent Raise
Protomer is a Pasadena-based biopharmaceutical company developing next-generation protein and peptide therapeutics using its MEPS platform to create small-molecule controllable, tunable-activity molecules, including glucose-responsive insulin and dual-homing targeted therapies.
